Bax released cytochrome C from the mitochondria, induced Caspase activation, and downregulated the survival protein p-PI3K, p-Akt, and anti-apoptotic Bcl-xL, which is certainly suggestive of their promising anti-cancer potential against OSCC. This evidence concerns the gene BAX and cancer.